Stock listing
OBI Stock Price, News, Filings & Events — Ondine Biomedical, Inc.
Selected listing: OBI · LSE · GBX · GB
This page tracks Ondine Biomedical, Inc.'s OBI:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OBI:LSE. OBI:LSE is the stock-level entry point for investors researching Ondine Biomedical, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ondine Biomedical, Inc. is a public company listed under the ticker OBI, operating in the UK market. The company has a market capitalization of approximately £96 million. Ondine focuses on developing innovative medical technologies aimed at improving patient outcomes.
- Ticker
- OBI:LSE
- Asset type
- Stock
- Market cap
- $78.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- GBX
Ondine Biomedical, Inc. OBI:LSE stock context
This page tracks Ondine Biomedical, Inc.'s OBI:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OBI:LSE. OBI:LSE is the stock-level entry point for investors researching Ondine Biomedical, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ondine Biomedical, Inc. is a public company listed under the ticker OBI, operating in the UK market. The company has a market capitalization of approximately £96 million. Ondine focuses on developing innovative medical technologies aimed at improving patient outcomes.
Latest news from Ondine Biomedical, Inc.
Ondine Biomedical, Inc. earnings calls
ONDINE BIOMEDICAL INC. (OBI) — Results for the year ended 31 December 2025
June 4, 2026 · Replay with transcript and chapters
ONDINE BIOMEDICAL INC. (OBI) — Interim financial results for the period ended 30 June 2025
September 26, 2025 · Replay with transcript and chapters
ONDINE BIOMEDICAL INC. (OBI) — Audited results for the year ended 31 December 2024
May 15, 2025 · Replay with transcript and chapters
ONDINE BIOMEDICAL INC. (OBI) — Half Year Results
September 30, 2024 · Replay with transcript and chapters
ONDINE BIOMEDICAL INC. (OBI) — Final Results
June 10, 2024 · Replay with transcript and chapters
ONDINE BIOMEDICAL INC. (OBI) — Interim Results
September 25, 2023 · Replay with transcript and chapters
Research Ondine Biomedical, Inc.
Ondine Biomedical, Inc. investor report
Review AI stock analysis and investor report context for OBI:LSE.
Ondine Biomedical, Inc. company profile
View the public company page for Ondine Biomedical, Inc. on 6ix.
Ondine Biomedical, Inc. news
Read company news and market updates connected to Ondine Biomedical, Inc..
Ondine Biomedical, Inc. investor events
Find investor webinars, events, and replay context for Ondine Biomedical, Inc..